We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Piezoelectric Sensor Measures Antibiotic Efficacy

By HospiMedica International staff writers
Posted on 25 Oct 2017
Image: Dr. Ward Johnson observes signals generated by bacteria coating quartz crystals (Photo courtesy of Burrus / NIST.
Image: Dr. Ward Johnson observes signals generated by bacteria coating quartz crystals (Photo courtesy of Burrus / NIST.
A new study claims that a quartz-based sensor could determine within an hour if an antibiotic will be effective against an infection.

The novel piezoelectric resonator, developed by researchers at the U.S. National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA), is extremely sensitive, and can detect the mechanical motion of microbes adhered to it, and their response to antibiotics. The sensor is composed of a thin piezoelectric quartz disk sandwiched between two electrodes. An alternating voltage at a stable frequency--near the crystal's resonant frequency--is applied to one electrode to excite crystal vibrations.

At the other electrode (on the opposite side of the crystal), oscillating voltages resulting from crystal response can be recorded; the fluctuations in the resonant frequency result from microbial mechanical activity of the several million bacterial cells coupled to the crystal surface. The ultra-sensitive approach can enable detection of cell-generated frequency fluctuations at a level of less than one part in 10 billion, with the amount of frequency noise generated correlating with the density of the living bacterial cells.

When E. coli bacteria were exposed to different antibiotics, the sensor showed that the frequency noise from the bacteria fell to zero within seven minutes of being treated with polymyxin B, and within 15 minutes of receiving ampicillin; the results mirrored the normal pharmacokinetics of the antibiotic drugs. The researchers added that since they used bacteria with paralyzed flagella, they concluded that the frequency fluctuations resulted from vibrations of cell walls. The study was published on September 22, 2017, in Nature Scientific Reports.

“Current tests require colonies of bacteria to be cultured for days, which can allow an improperly treated infection to advance and give the bacteria a chance to develop drug resistance,” concluded lead author Ward Johnson, PhD. “The NIST sensor is a quartz-crystal resonator that vibrates differently when bacterial cells on its surface change their behavior; it detects the mechanical motion of microbes to gauge a response to antibiotics…the amount of frequency noise emitted by the bacterial cells increased with the density of bacteria.”

Piezoelectricity, discovered in 1880 by French physicists Jacques and Pierre Curie, is a reversible effect in crystals that describes the internal generation of an electrical charge resulting from a mechanical force. For example, lead zirconate titanate crystals will generate measurable piezoelectricity when their static structure is deformed by about 0.1%. Conversely, the same crystals will change about 0.1% of their static dimension when an external electric field is applied to the material. The inverse piezoelectric effect is used in the production of ultrasonic sound waves.

Related Links:
National Institute of Standards and Technology

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Mammo DR Retrofit Solution
DR Retrofit Mammography

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more